Esperion Therapeutics, Inc. — Investor Relations & Filings
Esperion Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing medicines to reduce cardiovascular risk. The company specializes in once-daily, oral therapies for patients with elevated low-density lipoprotein cholesterol (LDL-C). Its portfolio is centered around adenosine triphosphate-citrate lyase (ACLY) inhibitors, a unique mechanism of action for which it brought the first treatment to market. Key products include NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe), which are approved in the U.S. and Europe. Esperion collaborates with commercial partners to facilitate global access to its medicines while its scientific team investigates new therapeutic opportunities through its pipeline.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| DEFM14A | 2026-06-08 | English | |
| 8-K | 2026-06-01 | English | |
| 10-Q - Esperion Therapeutics, Inc. (0001434868) (Filer) | 2026-05-08 | English | |
| 4 - Esperion Therapeutics, Inc. (0001434868) (Issuer) | 2026-03-18 | English | |
| 4 - Esperion Therapeutics, Inc. (0001434868) (Issuer) | 2026-03-18 | English | |
| 4 - Esperion Therapeutics, Inc. (0001434868) (Issuer) | 2026-03-18 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
12 filings
| |||||
| 47995449 | DEFM14A | 2026-06-08 | English | ||
| 47923358 | 8-K | 2026-06-01 | English | ||
| 44402054 | 10-Q - Esperion Therapeutics, Inc. (0001434868) (Filer) | 2026-05-08 | English | ||
| 32979258 | 4 - Esperion Therapeutics, Inc. (0001434868) (Issuer) | 2026-03-18 | English | ||
| 32979251 | 4 - Esperion Therapeutics, Inc. (0001434868) (Issuer) | 2026-03-18 | English | ||
| 32979254 | 4 - Esperion Therapeutics, Inc. (0001434868) (Issuer) | 2026-03-18 | English | ||
| 32966978 | 144 - Esperion Therapeutics, Inc. (0001434868) (Subject) | 2026-03-17 | English | ||
| 32966969 | 144 - Esperion Therapeutics, Inc. (0001434868) (Subject) | 2026-03-17 | English | ||
| 32966943 | 144 - Esperion Therapeutics, Inc. (0001434868) (Subject) | 2026-03-17 | English | ||
| 32891844 | 8-K - ESPERION THERAPEUTICS, INC. (0001434868) (Filer) | 2026-03-03 | English | ||
| 29771877 | 4 Filing | 2026-01-21 | English | ||
| 29771890 | 8-K Filing | 2026-01-12 | English | ||
|
2025
3 filings
| |||||
| 12218748 | FORM 4 | 2025-12-18 | English | ||
| 12218750 | FORM 4 | 2025-12-18 | English | ||
| 12218749 | FORM 4 | 2025-12-18 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
ANTEROGEN CO., LTD.
Develops and commercializes cell therapies and orphan drugs…
|
065660 | KR | Manufacturing |
|
Antibiotice S.A.
Pharmaceutical firm manufacturing generic medicines, anti-i…
|
ATB | RO | Manufacturing |
|
Anuh Pharma Ltd.
Manufacturer of APIs and bulk drugs specializing in Macroli…
|
ANUHPHR | IN | Manufacturing |
|
Apellis Pharmaceuticals, Inc.
Biopharmaceutical company developing therapies by targeting…
|
APLS | US | Manufacturing |
|
Apeloa Pharmaceutical Co.,Ltd.
Integrated provider of APIs, CDMO services, and finished dr…
|
000739 | CN | Manufacturing |
|
APEX HEALTHCARE BERHAD
Integrated pharmaceutical group manufacturing and distribut…
|
— | MY | Manufacturing |
|
ApicHope Pharmaceutical Group Co.,Ltd
Pharmaceutical firm focused on pediatric, chronic, and card…
|
300723 | CN | Manufacturing |
|
Apimeds Pharmaceuticals US, Inc.
Clinical-stage biopharma developing a bee venom drug and AI…
|
APUS | US | Manufacturing |
|
Apogee Therapeutics, Inc.
Clinical-stage biotech developing biologics for immunologic…
|
APGE | US | Manufacturing |
|
Apollomics Inc.
Clinical-stage biotech developing innovative oncology and c…
|
APLM | US | Manufacturing |
Esperion Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32771/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32771 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32771 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32771 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32771}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Esperion Therapeutics, Inc. (id: 32771)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.